CN Patent

CN113271951A — 使用奥贝胆酸的方法

Assigned to Intercept Pharmaceuticals Inc · Expires 2021-08-17 · 5y expired

What this patent protects

本公开内容涉及使用奥贝胆酸或其药学上可接受的盐或氨基酸缀合物用于减缓或逆转代偿性肝硬化的进展的方法。

USPTO Abstract

本公开内容涉及使用奥贝胆酸或其药学上可接受的盐或氨基酸缀合物用于减缓或逆转代偿性肝硬化的进展的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN113271951A
Jurisdiction
CN
Classification
—
Expires
2021-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.